| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3670578f3119780d17785dafab1f195b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_48a1d790e59d5075f974705e3a861d6d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9c285d96bb9f584ec47a7b7b3af3e245 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A45F2200-0516
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A45F2005-006 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A45F5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A44B11-2584 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-36 |
| filingDate |
2007-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0222c45b41c82a5b3f17b71dd2991f8c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_57c6e2f6940ffa3a51f5c6951a73a09f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_67d1202dabc6bbf01f1a23fd7c355408 |
| publicationDate |
2009-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2009088417-A1 |
| titleOfInvention |
Vanilloid receptor antagonist for prevention and treatment of drug dependence and addiction |
| abstract |
Disclosed is a composition for preventing and treating harmful actions caused by drugs of abuse. More particularly, disclosed is a pharmaceutical composition effective for preventing or treating dependence and spontaneous movements by using a drug acting against the vanilloid receptor Capsazepine, which is used as a drug acting against the vanilloid receptor, shows an excellent effect of alleviating conditions of cocaine dependence and addition during the development and recurrence thereof. Administration of the drug acting against the vanilloid receptor provides important information in developing an agent for preventing and treating drug dependence and addiction. |
| priorityDate |
2006-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |